PharmAla Biotech Executes Definitive License Agreement Granting Jupiter Neurosciences Exclusive U.S. Rights to ALA-002 Life Science Investing
Nektar Therapeutics Announces Start of Phase 3 ZENITH AD Program Evaluating Novel Regulatory T-Cell Biologic Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis Life Science Investing
TriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping Technology Life Science Investing
Arcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference Life Science Investing
Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis Life Science Investing
Lexston Mining Corporation Announces Drafting of Definitive Agreement Regarding Proposed Acquisition of Mineral Claims In Guyana Life Science Investing
Halozyme Announces Global Collaboration and License Agreement with Incyte to Support the Development of Subcutaneous Formulations of INCA033989 Using its ENHANZE® Technology Life Science Investing
Kalaris Expands Leadership Team Appointing Liisa Bayko as Chief Financial Officer Life Science Investing
Monopar Advances Launch Readiness with Addition of Veteran Commercial Executive Nicole Sweeny to Board of Directors and Expansion of Commercial Leadership Team Life Science Investing
Standard BioTools Announces Filing of Registration Statement in Connection with Treeline Biosciences Transaction Biotech Investing
